© 1996 by Oxford University Press
Journal of the National Cancer Institute, Vol. 88, No. 10, 675-679,
May 15, 1996
© 1996 Oxford University Press
Epidemiology of Brain Lymphoma Among People With or Without Acquired Immunodeficiency Syndrome
Viral Epidemiology Branch, Division of Cancer Etiology, National Cancer Institute Bethesda, MD
Environmental Epidemiology Branch, Division of Cancer Etiology, National Cancer Institute Bethesda, MD
Atlantic Research Corporation Rockville, MD.
Correspondene to: Angela Manns, M.D., M.P.H., National Institutes of Health, Executive Plaza North, Rm. 434, Bethesda, MD 20892.
BACKGROUND:: In recent years, brain lymphoma incidence has dramatically increased, presumably because of elevated risk of brain lymphoma among persons with acquired immunodeficiency syndrome (AIDS).
PURPOSE:: The objective of this study was to estimate independent incidence and survival rates of brain lymphoma among persons with or without AIDS and to understand the epidemiologic features of this cancer.
METHODS:: We linked AIDS and cancer registry reports at nine state and local health departments and compared the demographics, histology, and survival of brain lymphoma cases among persons with or without AIDS. The data were limited to people under 70 years of age. We calculated the incidence of brain lymphoma among persons with AIDS and compared observed cases with those expected. The differences were statistically analyzed using the Poisson test. Epidemiologic features of brain lymphoma in persons with or without AIDS were compared using the chi-squared test, the Student's t test, and the chi-squared test for linear trend. The logrank test was used to compare survival rates estimated by the Kaplan-Meier technique. All P values were two-sided.
RESULTS:: We matched 50 989 AIDS registry reports to 859 398 cancer registry reports (data from 1981 to 1990) and found 431 people with both AIDS and brain lymphoma. Among people with AIDS, those developing brain lymphoma versus those without brain lymphoma were more likely to be white (70% versus 59%; P<.001) and had homosexuality as their only human immunodeficiency virus risk factor (75% versus 64%; P<.001). Of the 431 patients, 223 developed brain lymphomas during 47 465 person-years of observation after diagnosis of AIDS. The absolute incidence rate of brain lymphoma among persons with AIDS was 4.7/1000 person-years (95% confidence interval = 4.1–5.3/1000 person-years), 3600-fold higher than the base-line rate in the general population. From 1980 through 1989, overall counts of brain lymphoma increased ninefold. Most of this increase was derived from persons with AIDS, but a substantial increase also occurred among persons without AIDS (0.04/100 000 in 1982 to 0.28/100 000 in 1989) (chi-squared test for trend; P<.05). The median survival was shortest for persons with AIDS and brain lymphoma (2 months), was intermediate for persons with brain lymphoma without AIDS (5–7 months), and was longest for persons with AIDS without brain lymphoma (14 months) (P<.05 for all comparisons).
CONCLUSIONS:: This analysis distinguishes the separate epidemiologies of brain lymphoma incidence among persons with or without AIDS and shows brain lymphoma incidence among persons with AIDS to be several thousand-fold higher than that in the general population. The study documents the overwhelming effect of AIDS-associated brain lymphoma on the overall rate in the general population and demonstrates a significantly rising trend, although of a lesser magnitude, among persons without AIDS.
IMPLICATIONS:: This study emphasizes a greater need to bring health care resources to this burgeoning epidemic. [J Natl Cancer Inst 1996;88:675–9]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I.S. Haldorsen, J. Krakenes, B.K. Krossnes, O. Mella, and A. Espeland CT and MR Imaging Features of Primary Central Nervous System Lymphoma in Norway, 1989-2003 AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 744 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Frenkel, K Hendler, T Siegal, E Shalom, and J Pe'er Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience Br J Ophthalmol, March 1, 2008; 92(3): 383 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, S. P. Mahesh, D. F. Shen, B. Liu, W. O. Siu, F. S. Hwang, Q.-C. Wang, C.-C. Chan, I. Pastan, and R. B. Nussenblatt Eradication of Tumor Colonization and Invasion by a B Cell-Specific Immunotoxin in a Murine Model for Human Primary Intraocular Lymphoma Cancer Res., November 1, 2006; 66(21): 10586 - 10593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bower, T. Powles, M. Nelson, S. Mandalia, B. Gazzard, and J. Stebbing Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma. J Natl Cancer Inst, August 2, 2006; 98(15): 1088 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fischer, E. Thiel, H.-A. Klasen, J. Birkmann, K. Jahnke, P. Martus, and A. Korfel Prospective trial on topotecan salvage therapy in primary CNS lymphoma Ann. Onc., July 1, 2006; 17(7): 1141 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Batchelor and J. S. Loeffler Primary CNS Lymphoma J. Clin. Oncol., March 10, 2006; 24(8): 1281 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Lin, K.-T. Kuo, S.-S. Chuang, S.-H. Kuo, J. H. Chang, K.-C. Chang, H.-C. Hsu, H.-F. Tien, and A.-L. Cheng Comparison of the Expression and Prognostic Significance of Differentiation Markers between Diffuse Large B-Cell Lymphoma of Central Nervous System Origin and Peripheral Nodal Origin Clin. Cancer Res., February 15, 2006; 12(4): 1152 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Mitterlechner, M Fiegl, H Muhlbock, W Oberaigner, S Dirnhofer, and A Tzankov Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000 J. Clin. Pathol., January 1, 2006; 59(1): 48 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Engels and J. J. Goedert Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Cancer: Past, Present, and Future J Natl Cancer Inst, March 16, 2005; 97(6): 407 - 409. [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Batchelor, B. R. Buchbinder, and N. L. Harris Case 1-2005 - A 35-Year-Old Woman with Difficulty Walking, Headache, and Nausea N. Engl. J. Med., January 13, 2005; 352(2): 185 - 194. [Full Text] [PDF]
|
|
|
|
|
|
K. Hoang-Xuan, L. Taillandier, O. Chinot, P. Soubeyran, U. Bogdhan, J. Hildebrand, M. Frenay, N. De Beule, J.Y. Delattre, and B. Baron Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group J. Clin. Oncol., July 15, 2003; 21(14): 2726 - 2731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Braaten, R. A. Betensky, L. de Leval, Y. Okada, F. H. Hochberg, D. N. Louis, N. L. Harris, and T. T. Batchelor BCL-6 Expression Predicts Improved Survival in Patients with Primary Central Nervous System Lymphoma Clin. Cancer Res., March 1, 2003; 9(3): 1063 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Smith, R. M. Braziel, S. Paoletti, M. Lipp, M. Uguccioni, and J. T. Rosenbaum Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma Blood, February 1, 2003; 101(3): 815 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ponzoni, M. R. Terreni, F. Ciceri, A. J. M. Ferreri, S. Gerevini, N. Anzalone, M. Valle, S. Pizzolito, and G. Arrigoni Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants Ann. Onc., November 1, 2002; 13(11): 1827 - 1832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakamura, T. Sakaki, H. Hashimoto, H. Nakase, E. Ishida, K. Shimada, and N. Konishi Frequent Alterations of the p14ARF and p16INK4a Genes in Primary Central Nervous System Lymphomas Cancer Res., September 1, 2001; 61(17): 6335 - 6339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Jukich, B. J. McCarthy, T. S. Surawicz, S. Freels, and F. G. Davis Trends in incidence of primary brain tumors in the United States, 1985-1994 Neuro-oncol, July 1, 2001; 3(3): 141 - 151. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Ammassari, A. Cingolani, P. Pezzotti, A. De Luca, R. Murri, M. L. Giancola, L. M. Larocca, and A. Antinori AIDS-related focal brain lesions in the era of highly active antiretroviral therapy Neurology, October 24, 2000; 55(8): 1194 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Biggar, M. Frisch, J. J. Goedert, and for the AIDS-Cancer Match Registry Study Group Risk of Cancer in Children With AIDS JAMA, July 12, 2000; 284(2): 205 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Montesinos-Rongen, R. Kuppers, D. Schluter, T. Spieker, D. Van Roost, C. Schaller, G. Reifenberger, O. D. Wiestler, and M. Deckert-Schluter Primary Central Nervous System Lymphomas Are Derived from Germinal-Center B Cells and Show a Preferential Usage of the V4-34 Gene Segment Am. J. Pathol., December 1, 1999; 155(6): 2077 - 2086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Rickert, B. Dockhorn-Dworniczak, R. Simon, and W. Paulus Chromosomal Imbalances in Primary Lymphomas of the Central Nervous System Am. J. Pathol., November 1, 1999; 155(5): 1445 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. O'Neill, C.-H. Wang, J. R. O'Fallon, J. P. Colgan, J. D. Earle, R. L. Krigel, L. D. Brown, and W. J. McGinnis The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: Cognitive function and performance status Neuro-oncol, July 1, 1999; 1(3): 196 - 203. [Abstract] [PDF]
|
|
|
|
|
|
A. Antinori, G. De Rossi, A. Ammassari, A. Cingolani, R. Murri, D. Di Giuda, A. De Luca, F. Pierconti, T. Tartaglione, M. Scerrati, et al. Value of Combined Approach With Thallium-201 Single-Photon Emission Computed Tomography and Epstein-Barr Virus DNA Polymerase Chain Reaction in CSF for the Diagnosis of AIDS-Related Primary CNS Lymphoma J. Clin. Oncol., February 1, 1999; 17(2): 554 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Surawicz, B. J. McCarthy, V. Kupelian, P. J. Jukich, J. M. Bruner, F. G. Davis, and the collaborating registries of the Central Brain Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994 Neuro-oncol, January 1, 1999; 1(1): 14 - 25. [Abstract] [PDF]
|
|
|
|
 |
|
 V. Koseoglu, A. Emin Kurekci, R. Akin, O. Gunhan, T. Ucoz, O. Ozcan, and E. Gokcay Primary Epidural Non-Hodgkin's Lymphoma With Cervical Location in an HIV Negative Child: Case Report J Child Neurol, October 1, 1998; 13(10): 520 - 522. [PDF]
|
|
|
|
|
|
L. M. Larocca, D. Capello, A. Rinelli, S. Nori, A. Antinori, A. Gloghini, A. Cingolani, A. Migliazza, G. Saglio, S. Cammilleri-Broet, et al. The Molecular and Phenotypic Profile of Primary Central Nervous System Lymphoma Identifies Distinct Categories of the Disease and Is Consistent With Histogenetic Derivation From Germinal Center-Related B Cells Blood, August 1, 1998; 92(3): 1011 - 1019. [Abstract] [Full Text] [PDF]
|
|